戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ), dexamethasone, and dolasetron mesylate, a serotonin receptor antagonist.
2 1 receptor antagonists (NK1-RAs) and the new serotonin receptor antagonist (5HT3-RA) palonosetron.
3 longer recommends the combination of a 5-HT3 serotonin receptor antagonist and dexamethasone for the
4      Hairless mice were injected with PAF or serotonin receptor antagonists and then exposed to solar
5                                 Type 2 and 3 serotonin receptor antagonists attenuated serotonin's po
6                         Also, the PAF and/or serotonin receptor antagonists blocked skin cancer progr
7                       Spinal methysergide, a serotonin receptor antagonist, blocked apnoea-induced LT
8 cemia in mice was blocked by the nonspecific serotonin receptor antagonist cyproheptadine and the spe
9 SSRI fluoxetine and fluvoxamine and the 5-HT serotonin receptor antagonist cyproheptadine were conduc
10 nsulin receptor, or pharmacologically by the serotonin receptor antagonist cyproheptadine.
11 ination of a 5-hydroxytryptamine-3 (5-HT(3)) serotonin receptor antagonist, dexamethasone, and aprepi
12 sed as peripheral subtype-selective 5-HT(2B) serotonin receptor antagonists for heart and lung fibros
13 eatment of mammary epithelial membranes with serotonin receptor antagonists increased their transepit
14                                              Serotonin receptor antagonists may thus be useful in the
15 icated healthy comparison women received the serotonin receptor antagonist metergoline as part of a d
16 ytryptamine affects phosphate excretion, the serotonin receptor antagonist methiothepin (20 microgram
17          The bilateral administration of the serotonin receptor antagonist methysergide (2.5 microg,
18 or depotentiation, by DSI was blocked by the serotonin receptor antagonist methysergide and mimicked
19                             Furthermore, the serotonin receptor antagonist methysergide blocked this
20 ere occluded by serotonin and blocked by the serotonin receptor antagonist methysergide, suggesting t
21                        Pretreatment with the serotonin receptor antagonists methysergide (4 mg/kg, i.
22                             A broad-spectrum serotonin receptor antagonist (methysergide) or protein
23 atients intolerant of or refractory to 5-HT3 serotonin receptor antagonists, neurokinin-1 receptor an
24 polarization of neutrophils, suggesting that serotonin-receptor antagonists or serotonin reuptake inh
25                                     Although serotonin receptor antagonists remain key in the multimo
26 ed as an affinity matrix in the screening of serotonin receptor antagonists with known affinities for
27                                  The PAF and serotonin receptor antagonists worked in a synergistic f